Novocure Announces Addition to Its Board of Directors

first_imgLocal NewsBusiness WhatsApp Pinterest Previous articleLeafs winger Wayne Simmonds out 6 weeks with broken wristNext articleIronwood Pharmaceuticals Announces CEO Transition Digital AIM Web Support Twitter By Digital AIM Web Support – February 8, 2021 Novocure Announces Addition to Its Board of Directors Facebookcenter_img WhatsApp Facebook Pinterest Twitter TAGS  ST. HELIER, Jersey–(BUSINESS WIRE)–Feb 8, 2021– Novocure (NASDAQ: NVCR) has announced an addition to its board of directors. Timothy J. Scannell, an experienced executive leader, was elected to Novocure’s board on Feb. 5. “We are extremely pleased to welcome Tim to our board of directors,” said Bill Doyle, Novocure’s Executive Chairman. “His extensive and impressive background at Stryker, one of the world’s leading medical technology companies, will provide invaluable guidance as we advance product development and prepare for an anticipated period of significant innovation and growth.” Mr. Scannell is currently President and Chief Operating Officer of Stryker Corporation where he is responsible for all of Stryker’s operating businesses and regions, a position he has held since August 2018. Prior to this position, he served as Group President of Stryker’s MedSurg and Neurotechnology group from 2009 to 2018. He also serves on the board of directors for Insulet Corporation. Mr. Scannell holds bachelor’s and master’s degrees in business administration from the University of Notre Dame. Mr. Scannell has been appointed to the Nominating and Corporate Governance Committee of the Board, effective upon his election to the board. About Novocure Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Tumor Treating Fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized products are approved for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and liver cancer. Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York City. Additionally, the company has offices in Germany, Switzerland, Japan and Israel. For additional information about the company, please visit or follow us at Forward-Looking Statements In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Novocure’s current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, clinical trial progress, development of potential products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, coverage, collections from third-party payers and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” or other words and terms of similar meaning. Novocure’s performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions as well as issues arising from the COVID-19 pandemic and other more specific risks and uncertainties facing Novocure such as those set forth in its Annual Report on Form 10-K filed on February 27, 2020 and its Quarterly Report on Form 10-Q filed on April 30, 2020, as amended to date, with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Novocure does not intend to update publicly any forward-looking statement, except as required by law. Any forward-looking statements herein speak only as of the date hereof. The Private Securities Litigation Reform Act of 1995 permits this discussion. View source version on CONTACT: Investors: Gabrielle Fernandes [email protected] 603-206-7047Media: Jaclyn Stahl [email protected] 212-767-7516 KEYWORD: JERSEY EUROPE INDUSTRY KEYWORD: RESEARCH GENERAL HEALTH RADIOLOGY PHARMACEUTICAL ONCOLOGY MEDICAL DEVICES CLINICAL TRIALS SCIENCE BIOTECHNOLOGY FDA OTHER SCIENCE HEALTH SOURCE: Novocure Copyright Business Wire 2021. PUB: 02/08/2021 04:00 PM/DISC: 02/08/2021 04:01 PM read more

‘Rumble with the Agents’ needs knockout property agent boxers!

first_imgThis year ‘Rumble with the Agents’, the hugely popular annual white-collar charity boxing event hosted by Landlord Action and sponsored by Hamilton Fraser, is fundraising for Inclusion Barnet, a charity which provides vital support for people with disabilities.Paul Shamplina set up the event six years ago and runs it with his wife Rita, now he’s looking for ten individuals from the property sector to try their hand at boxing.You need to sign up by 7th February to join this free, fully structured and supervised boxing training program to ensure optimum physical fitness and teach participants the correct techniques will be provided by JA Boxing in north London.Participants are not required to have any previous experience, just a desire to learn a new skill, get fit in three months and support an excellent local charity.THE CHARITYInclusion Barnet is a Deaf and Disabled People’s Organisation (DDPO), which means that their staff and trustees have lived experience of disability, including mental health issues and long-term conditions. They use their lived experience to raise awareness and educate society about the barriers faced by disabled people and how people can work together to remove those barriers. Those living with disability often find it very hard to access to the services and resources they need to help them live the life they want to live, which is where Inclusion Barnet provides vital support.PAUL SHAMPLINA SAYS “I’ve been a keen boxer for many years. Boxing not only helps me keep fit, it’s a stress reliever, motivator, confidence builder and has taught me discipline. I know an increasing number of boxing clubs are doing an outstanding job to ensure that the experiences they offer are fully inclusive, and that is why we feel that this year’s charity is a perfect fit for Rumble with the Agents 2020.”As before, the evening will consist of five fights, which will be three two-minute rounds each, a sit down three-course meal, charity auction and raffle.The event, which so far has raised a total of £93,000 for various charities, is open to agents, property professionals, suppliers and landlords and will take place on Thursday 21st May 2020, at Holiday Inn, Avenue Banqueting, 58 Regents Park Road, London, N3 3JN.To find out more, volunteer to take part, buy tickets or donate something for the raffle/ auction please email Rita Shamplina on [email protected] or call 07790 569501.Tickets to attend ‘Rumble with the Agents’ are now on sale ( Shamplina Rumble with the Agents February 3, 2020Nigel LewisAny comments? Cancel replyYou must be logged in to post a comment.Please note: This is a site for professional discussion. Comments will carry your full name and company.This site uses Akismet to reduce spam. Learn how your comment data is processed.Related articles BREAKING: Evictions paperwork must now include ‘breathing space’ scheme details30th April 2021 City dwellers most satisfied with where they live30th April 2021 Hong Kong remains most expensive city to rent with London in 4th place30th April 2021 Home » News » Agencies & People » ‘Rumble with the Agents’ needs knockout property agent boxers! previous nextAgencies & People‘Rumble with the Agents’ needs knockout property agent boxers!Paul Shamplina of Landlord Action is raising funds for charity Inclusion Barnet which provides support for people with disabilities.Sheila Manchester3rd February 20200545 Viewslast_img read more

KL Rahul named in India A squad for 1st four-day match vs England Lions

first_imgIndia opener KL Rahul has been named in the 15-member squad of India A for the first of the two four-day games against England Lions. The match will be played from February 7 in Wayanad.Rahul’s suspension over the Koffee With Karan controversy was lifted pending the appointment of an ombudsman earlier this month. Rahul was sent home from Australia along with Hardik Pandya as the duo missed the three-match ODI series in Australia.While Hardik Pandya rejoined the India squad in the ongoing ODI series in New Zealand, KL Rahul has been playing the unofficial one-dayers for India A against England Lions in Thiruvananthapuram. Rahul had made 13 and 43 in his two appearances for the Rahul Dravid-coached side earlier this week.The India A squad for the four-day match will be led by Maharashtra batsman, Ankit Bawne, who is also leading the one-day side. India A will take on the England Lions in the final one-dayer on Thursday. India A have so far won four matches and will be hoping for a whitewash in the last match.”The All-India Senior Selection Committee picked the India A team for the first four-day game to be played against England Lions from 7th February in Wayanad,” a BCCI release said.Shardul Thakur, who picked up four wickets to set up India’s six-wicket win in the fourth one-dayer on Tuesday, is also part of the squad. Navdeep Saini and India discard Varun Aaron also find a place in the Bawne-led India A side.KL Rahul’s form in the upcoming series will be crucial as he is still being considered for the back-up opener’s role in the World Cup. The Karnataka batsman will be hoping to get back into the India limited-overs squad for the home series against Australia, starting February 24 in Bengaluru.advertisementIndia A squad for the first four-day game vs England Lions: Ankit Bawne (C), KL Rahul, AR Easwaran, Priyank Panchal, Ricky Bhui, Siddhesh Lad, K.S. Bharat (WK), Jalaj Saxena, S Nadeem, Mayank Markande, Navdeep Saini, Shardul Thakur, Avesh Khan, Varun Aaron.Also Read | Sanjay Manjrekar-Michael Vaughan war-of-words escalates over flawed approach tweetAlso Read | Hardik Pandya was just dying to get into the thick of things: R SridharAlso Read | India look to try out reserve players in Hamilton ODI vs New ZealandAlso See:last_img read more